Zota Health Care Limited announced strong financial results for the third quarter and nine months ended December 31, 2025. The company reported a consolidated revenue from operations of ₹14,295.14 lakhs for Q3FY26, marking a significant year-on-year growth of 98.2% compared to ₹7,212.38 lakhs in Q3FY25. Consolidated Gross Profit increased by 113.9% to ₹8,617.82 lakhs in Q3FY26 from ₹4,029.15 lakhs in the same period last year. However, consolidated EBITDA stood at ₹127.58 lakhs, impacted by higher operating expenses related to ongoing expansion initiatives for over 400 stores. The company added 276 new stores during the quarter, expanding its Davaindia Network to 2,331 stores nationwide. Key operational highlights include the incorporation of a wholly owned subsidiary, KMHP Ventures Limited, to market and trade pharmaceutical products, and the subscription to the rights issue of its subsidiary, Davaindia Health Mart Limited. The company also highlighted the successful completion of a ₹350 crore QIP to accelerate store rollouts and support working capital needs. Mr. Ketan Kumar Zota, Chairman, expressed confidence in the company's growth trajectory, driven by the Davaindia store scale-up. He reiterated the ambition to cross 5,000 Davaindia stores by March 2029, focusing on unit economics, operating efficiencies, and sustained profitability.
